Cleveland Biolabs, Inc. (CBLI) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q4 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $1.95 million versus the consensus estimate of $1 million.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
